Direct infusion of fenoldopam into the renal arteries to protect against contrast-induced nephropathy in patients at increased risk.


1. Fenoldopam is a dopamine-like receptor agonist that selectively increases renal medullary blood flow. Despite promising pathophysiology, randomized controlled trials have failed to show a benefit with intravenous infusion of fenoldopam in preventing contrast-induced nephropathy (CIN). 2. The aims of the present study were to examine the efficacy of… (More)
DOI: 10.1111/j.1440-1681.2012.05709.x